Introduction
In vitro diagnostics (IVD) are tests done on samples such as blood or tissue that have been
taken from the human body. In vitro diagnostics can detect diseases or other conditions, and
can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely
to benefit from specific treatments or therapies. These in vitro diagnostics can include next
generation sequencing tests, which scan a person’s DNA to detect genomic variations.
Overview of Indian Market
According to a market research report predicts that the “Indian IVD Market” will grow at a
compound annual growth rate of ~13.0% during the forecast period 2019–2025. The market
is immensely driven by the increase in the number of chronic and lifestyle-related disorders,
increasing cancer incidences, growing awareness on the importance of early diagnosis and
prevention, and improving access to healthcare facilities and diagnostic set-ups.
The diagnostics market is experiencing quick progress due to advancements in oncology,
molecular diagnostics, point-of-care, and novel sectors such as companion diagnostics in both
developed and developing economies. The market is driven by an increase in the elderly
population, intensification of chronic diseases, pandemic situations in case of infectious
diseases, and the growing importance of medical diagnostics.
Major Players:
Danaher Corporation
Abbott Laboratories
bioMerieux
F. Hoffmann-La Roche
Siemens
Transasia Bio-Medicals Ltd.
By Product type:
IVD Reagents
IVD Equipment
IVD reagents holds the major share in the Indian IVD market followed by IVD equipment in
2018. Transasia Bio-Medicals is the leader of India’s IVD market with over 45,000
installation bases across India.
By End Users:
Hospitals
Laboratories
Home Care
Academic and Research Institute
Others
Hospitals hold major share in the Indian IVD market. Hospitals and reference laboratories are
expecting the development of products that will provide reliable results at great speed to
reduce wrong diagnosis and treatment time.
Key Competitive Facts
The future growth of the Indian in Vitro Diagnostic market will be driven by Tier-II
and Tier-III cities and that is where the price of the products and testing consumables
will matter the most.
Hospitals and reference laboratories are expecting the development of products that
will provide reliable results at great speed to reduce wrong diagnosis and treatment
time.
India IVD Market Segment Analysis
Biochemistry is the leading segment in India IVD market.
Immunochemistry holds the 2nd position in India IVD market being followed by
Hematology.
Microbiology is the fastest growing segment of the Indian IVD market.
The Indian urinalysis (instruments and reagents) market was in the range of US$ 20 -
25 Million in 2018.
Molecular diagnostics and Coagulation segments are competing closely with each
other to grab the maximum share.
